Sudarshan Pharma Industries Ltd - 543828 - Outcome Of The Meeting Of Board Of Directors Of The Company Held On July 21, 2023
The Board of Directors at its meeting held on July 21, 2023 approved the agendas contained in the Outcome. Due to the restriction on the characters limit, the Outcome of the Board meeting is attached in the PDF Format for your records. Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Dividend Updates
The Board of Directors at its meeting held on July 21, 2023 approved the agendas contained in the outcome. Due to restriction of character limit, the outcome of the Board Meeting is attached in the PDF Format for your record. Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Change in Management
The Board of the Directors at its meeting held on July 21, 2023 approved the agendas contained in the outcome. Due to restrictions on the character limit, the Outcome of the Board Meeting is attached in the PDF format for your records. Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Of The Company Held On July 21, 2023
The Board of Directors at its Meeting held on July 21, 2023 approved the agendas contained in the outcome. Due to restriction on character limit, the Outcome of the Board meeting is attached in the PDF format for your records. Sudarshan Pharma Industries Ltd - 543828 - Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On July 21, 2023.
Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2023 ,inter alia, to consider and approve Notice is hereby given that a Meeting of the Board of Directors of the company is scheduled to be held on Friday, July 21, 2023 at 02:00 PM, inter-alia, to consider and approve the following business: 1. To recommend Final Dividend to the equity shareholders of the Company for the Financial Year 2022-2023. 2. To approve AGM Notice along with Annual Report 3. To fix up date, time and venue for annual general meeting; 4. To fix cut-off date for dispatch of annual report 5. To fix cut-off date for e-voting and to fix e-voting period 6. To fix record date for final dividend 7. Re-appointment of Managing Director of the Company. 8. Re-appointment of Joint Managing Director of the Company. 9. To consider and approve ESOP. 10. Appointment of Additional Director (Independent) 11. Increase in Authorized Share Capital 12. To approve related party transaction Sudarshan Pharma Industries Ltd - 543828 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Sudarshan Pharma Industries Limited hereby submits Certificate under Regulation 74(5) of SEBI of (Depository and participants) Regulations, 2018 for the Quarter ended June 30, 2023. Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Resignation of Director
Sudarshan Pharma Industries Limited intimates to the stock exchange about Resignation of Independent Director under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015. Sudarshan Pharma Industries Ltd - 543828 - Statement Of Variation For Proceeds Of Public Issue Pursuant To Reg. 32 Of SEBI (LODR) Regulations, 2015.
This is in furtherance to our letter having reference number SPIL/CS/SE/2022-2023/11 dated 26.05.2023 and with reference to the captioned subject matter, please find enclosed a Statement of Variation in utilization of funds raised through Public Issue pursuant to Reg. 32 of SEBI (LODR) Regulations, 2015 which was placed before the 01/2023-2024 Meeting of the Audit Committee held on May 26, 2023, for review, in the format prescribed by SEBI vide their Circular no. CIR/CFD/CMD1/162/2019 dated December 24, 2019. Sudarshan Pharma Industries Ltd - 543828 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Sudarshan Pharma Industries Limited hereby intimates the stock exchange regarding the Newspaper Advertisement - Results for the Half-Year and Year ended March 31, 2023. Sudarshan Pharma Industries Ltd - 543828 - Intimation Regarding Statement Of Variation Pursuant To Reg. 32(1)(B) Of SEBI(LODR)Regulations, 2015
Sudarshan Pharma Industries Limited intimates the Stock Exchange regarding Statement of Variation pursuant to Reg. 32(1)(b) of SEBI(LODR)Regulations, 2015